ReachRxResearch
Home
Research
Sign Up
Predictive Model for Identifying Fibrotic Interstitial Lung Abnormalities on Computed Tomography for Respiratory Specialists
Back to Research Hub
  1. Home
  2. Research Hub
  3. Predictive Model for Identifying Fibroti…

Predictive Model for Identifying Fibrotic Interstitial Lung Abnormalities on Computed Tomography for Respiratory Specialists

Respirology·October 7Open Access
Respiratory SystemPractice changingInterstitial Lung AbnormalitiesInterstitial Lung DiseaseProspective Cohort StudyClinical Prediction ModelSerum BiomarkerAdultSurfactant Protein-D

Summary

View source

What was studied

A prediction model using four non-radiological variables (age, pack-years, fine crackles, elevated serum surfactant protein-D) was developed and temporally validated to identify fibrotic interstitial lung abnormalities (ILAs) on CT, in a multicenter prospective Japanese cohort (derivation n=164, 2022–2023; validation n=207, 2023–2024), with correlation to 24-month functional decline and treatment initiation within 3 years.

Key findings

The four-variable model achieved an AUC of 0.79 (derivation) and 0.76 (validation; pooled AUC 0.76, 95% CI 0.68–0.82) with good calibration and minimal between-center heterogeneity; fibrotic ILAs comprised 82% of cases, and ~60% subsequently met ATS-defined ILD criteria. A simplified integer score performed similarly (AUC 0.79/0.75) and correlated with functional decline (%FVC ≥10% or %DLco ≥15%) and treatment initiation.

Study limitations

The cohort is from a single country (Japan), limiting generalizability to other ethnic groups. The validation was temporal rather than fully independent, and the study relied on a referral-based multicenter cohort, which may not reflect community prevalence of ILAs.

Clinical implications

Clinicians can use a simple four-variable bedside score (age, smoking pack-years, fine crackles, serum SP-D) to identify patients with fibrotic ILAs at risk of progression, supporting earlier risk stratification without requiring radiological subspecialty input. Patients flagged as high-risk should be considered for closer pulmonary function monitoring and earlier treatment discussion.

Caveats

  • Approximately 82% of ILA cases were fibrotic, suggesting a highly selected referral population that may overestimate fibrotic ILA prevalence in general practice
  • Temporal validation was performed at the same centers as derivation; fully external validation in independent institutions has not yet been conducted
  • The cohort is entirely Japanese, so the model's performance in non-Asian or mixed-ethnicity populations is unknown

Related Questions

Explore related topics

How do interstitial lung abnormalities on CT progress to clinical ILD over time?What clinical and biomarker predictors identify high-risk fibrotic ILA patients?When should treatment be initiated for progressive fibrotic interstitial lung abnormalities?

Publication Details

Year
2026
Journal
Respirology
Sample Size
n=371
Source
View article
Keep scrolling
More content below.
Up Next